Back to Search
NILOUFAR FARID MD
MD
Psychiatry Physician
NPI: 1023670213Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
A199461(CA)
Research & Publications (20)
Miscellaneous conditions of the shoulder: anatomical, clinical, and pictorial review emphasizing potential pitfalls in imaging diagnosis.
PMID 18406557·Eur J Radiol·2008
6-review
Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrel.
PMID 19047469·Drug Metab Dispos·2009
8-other
Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases.
PMID 19589151·Arthritis Res Ther·2009
8-other
Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in Tunisia.
PMID 19636371·J Biomed Biotechnol·2009
8-other
Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects.
PMID 19530977·Curr Med Res Opin·2009
3-trial
Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma.
PMID 19156774·J Pathol·2009
8-other
Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjects.
PMID 19637095·Platelets·2009
4-observational
Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors.
PMID 19107232·Neoplasia·2009
4-observational
Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs.
PMID 19280520·Xenobiotica·2009
4-observational
Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
PMID 18303127·J Clin Pharmacol·2008
2-rct
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects.
PMID 18569863·Platelets·2008
2-rct
Molecular cloning, expression and characterization of a functional GSTmu class from the cattle tick Boophilus annulatus.
PMID 18241993·Vet Parasitol·2008
7-preclinical
Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
PMID 18786302·Curr Med Res Opin·2008
2-rct
A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
PMID 18217157·Thromb Haemost·2008
4-observational
The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration.
PMID 18278193·Thromb Haemost·2008
4-observational
Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS.
PMID 18829199·J Pharm Biomed Anal·2008
8-other
Lack of association of VDR gene polymorphisms with thyroid autoimmune disorders: familial and case/control studies.
PMID 17943423·J Clin Immunol·2008
8-other
Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.
PMID 19025429·Pharmacotherapy·2008
2-rct
Prasugrel, a new thienopyridine antiplatelet drug, weakly inhibits cytochrome P450 2B6 in humans.
PMID 18094219·J Clin Pharmacol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via DUKE UNIVERSITY HOSPITAL · 2 locations total
- Address
- 2301 ERWIN RD
DURHAM, NC 27705 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1023670213
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile